Showing posts with label negative trials. Show all posts
Showing posts with label negative trials. Show all posts
Saturday, January 28, 2012
Comparing Poly (ADP–Ribose) Polymerase Inhibitors With Standard Chemotherapy in BRCA-Mutated, Recurrent Ovarian Cancer: Lessons Learned From a Negative Trial (Olaparib)
"...Thus, although the study by Kaye et al11 does not show a clear advantage of olaparib compared with PLD, it is noteworthy for what it teaches us about the difficulties in performing and interpreting the results of randomized trials that involve this promising class of new agents in patients with recurrent EOC."
add your opinions
negative trials
,
Olaparib
Subscribe to:
Posts
(
Atom
)